These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37996455)

  • 1. Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson's study.
    Pachchek S; Landoulsi Z; Pavelka L; Schulte C; Buena-Atienza E; Gross C; Hauser AK; Reddy Bobbili D; Casadei N; May P; Krüger R;
    NPJ Parkinsons Dis; 2023 Nov; 9(1):156. PubMed ID: 37996455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GBA1 in Parkinson's disease: variant detection and pathogenicity scoring matters.
    Gabbert C; Schaake S; Lüth T; Much C; Klein C; Aasly JO; Farrer MJ; Trinh J
    BMC Genomics; 2023 Jun; 24(1):322. PubMed ID: 37312046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex distribution and classification of GBA1 variants in an Italian cohort of Parkinson's disease patients analyzed over the last seventeen years.
    Panteghini C; Reale C; Colangelo I; Suerz M; Catania A; Garavaglia B; Invernizzi F
    Parkinsonism Relat Disord; 2023 Dec; 117():105919. PubMed ID: 37948831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations.
    Rizig M; Bandres-Ciga S; Makarious MB; Ojo O; Crea PW; Abiodun O; Levine KS; Abubakar S; Achoru C; Vitale D; Adeniji O; Agabi O; Koretsky MJ; Agulanna U; Hall DA; Akinyemi R; Xie T; Ali M; Shamim EA; Ani-Osheku I; Padmanaban M; Arigbodi O; Standaert DG; Bello A; Dean M; Erameh C; Elsayed I; Farombi T; Okunoye O; Fawale M; Billingsley KJ; Imarhiagbe F; Jerez PA; Iwuozo E; Baker B; Komolafe M; Malik L; Nwani P; Daida K; Nwazor E; Miano-Burkhardt A; Nyandaiti Y; Fang ZH; Obiabo Y; Kluss JH; Odeniyi O; Hernandez D; Odiase F; Tayebi N; Ojini F; Sidranksy E; Onwuegbuzie G; D'Souza AM; Osaigbovo G; Berhe B; Osemwegie N; Reed X; Oshinaike O; Leonard H; Otubogun F; Alvarado CX; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Iwaki H; Kim JJ; Morris HR; Hardy J; Nalls M; Heilbron K; Norcliffe-Kaufmann L; ; Blauwendraat C; Houlden H; Singleton A; Okubadejo N
    medRxiv; 2023 May; ():. PubMed ID: 37398408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging and genetics in Parkinson's disease: assessment of the GBA1 mutation.
    Ghatti S; Yoon E; Lopez G; Ehrlich D; Horovitz SG
    J Neurol; 2022 Oct; 269(10):5347-5355. PubMed ID: 35604467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of
    Stoker TB; Camacho M; Winder-Rhodes S; Liu G; Scherzer CR; Foltynie T; Evans J; Breen DP; Barker RA; Williams-Gray CH
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):695-702. PubMed ID: 32303560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
    den Heijer JM; Cullen VC; Quadri M; Schmitz A; Hilt DC; Lansbury P; Berendse HW; van de Berg WDJ; de Bie RMA; Boertien JM; Boon AJW; Contarino MF; van Hilten JJ; Hoff JI; van Mierlo T; Munts AG; van der Plas AA; Ponsen MM; Baas F; Majoor-Krakauer D; Bonifati V; van Laar T; Groeneveld GJ
    Mov Disord; 2020 Sep; 35(9):1667-1674. PubMed ID: 32618053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson's disease.
    Zhou Y; Wang Y; Wan J; Zhao Y; Pan H; Zeng Q; Zhou X; He R; Zhou X; Xiang Y; Zhou Z; Chen B; Sun Q; Xu Q; Tan J; Shen L; Jiang H; Yan X; Li J; Guo J; Tang B; Wu H; Liu Z
    NPJ Parkinsons Dis; 2023 Sep; 9(1):129. PubMed ID: 37658046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Hereditary and GBA1-Related Parkinsonism in Latin America: A Systematic Review and Meta-Analysis.
    Saffie Awad P; Teixeira-Dos-Santos D; Santos-Lobato BL; Camargos S; Cornejo-Olivas M; de Mello Rieder CR; Mata IF; Chaná-Cuevas P; Klein C; Schumacher Schuh AF
    Mov Disord; 2024 Jan; 39(1):6-16. PubMed ID: 37921246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal evaluation of olfactory function in individuals with Gaucher disease and
    Lopez GJ; Lichtenberg J; Tayebi N; Ryan E; Lecker AL; Sidransky E
    Front Neurol; 2022; 13():1039214. PubMed ID: 36330429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser.
    Parlar SC; Grenn FP; Kim JJ; Baluwendraat C; Gan-Or Z
    Mov Disord; 2023 Mar; 38(3):489-495. PubMed ID: 36598340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations in
    Smith LJ; Lee CY; Menozzi E; Schapira AHV
    Front Neurol; 2022; 13():971252. PubMed ID: 36034282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Gauchian genotyping of
    Tayebi N; Lichtenberg J; Hertz E; Sidransky E
    medRxiv; 2023 Oct; ():. PubMed ID: 37986861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients.
    Slingerland S; van der Zee S; Carli G; Slomp AC; Boertien JM; d'Angremont E; Bohnen NI; Albin RL; van Laar T
    Brain; 2024 Mar; 147(3):900-910. PubMed ID: 37748026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy.
    Huh YE; Usnich T; Scherzer CR; Klein C; Chung SJ
    J Mov Disord; 2023 Sep; 16(3):261-278. PubMed ID: 37302978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
    Toffoli M; Chohan H; Mullin S; Jesuthasan A; Yalkic S; Koletsi S; Menozzi E; Rahall S; Limbachiya N; Loefflad N; Higgins A; Bestwick J; Lucas-Del-Pozo S; Fierli F; Farbos A; Mezabrovschi R; Lee-Yin C; Schrag A; Moreno-Martinez D; Hughes D; Noyce A; Colclough K; Jeffries AR; Proukakis C; Schapira AHV
    Neurobiol Dis; 2023 Nov; 188():106343. PubMed ID: 37926171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants.
    Pal GD; Corcos DM; Metman LV; Israel Z; Bergman H; Arkadir D
    Mov Disord; 2023 Dec; 38(12):2155-2162. PubMed ID: 37916476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freezing of gait in Parkinson's disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life.
    Ou R; Li C; Wei Q; Liu K; Lin J; Yang T; Xiao Y; Jiang Q; Cheng Y; Hou Y; Zhang L; Song W; Chen X; Lai X; Shang H
    Front Neurosci; 2023; 17():1288631. PubMed ID: 38089969
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.